[Studies on the detection of antibodies to Neisseria gonorrheae using pilus antigen]

Dermatologische Monatschrift
|January 1, 1989
PubMed

Insights

Antibody testing for gonorrheal disease showed 75% of patients had antibodies against the pilus antigen. This indirect hemagglutination test offers potential for diagnosing gonorrhea, though result evaluation needs consideration.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Neisseria gonorrhoeae is a significant cause of sexually transmitted infections.
  • Accurate and timely diagnosis of gonorrhea is crucial for effective treatment and public health.
  • Pilus antigen is a key component of Neisseria gonorrhoeae, involved in adherence and infection.

Purpose of the Study:

  • To investigate the presence of antibodies against the pilus antigen of Neisseria gonorrhoeae strain F-62 in patients with gonorrhea.
  • To evaluate the diagnostic potential of detecting anti-pilus antibodies using indirect hemagglutination.
  • To determine the specificity of this antibody response in relation to gonorrheal disease.

Main Methods:

  • Sera from 100 patients diagnosed with gonorrhea (confirmed by positive Neisseria gonorrhoeae culture) were analyzed.
  • Indirect hemagglutination assay was employed to detect antibodies against the pilus antigen of strain F-62.
  • Diagnostic criteria included positive cultures; positive smear tests were used sparingly with confirmed infection chains.

Main Results:

  • A significant proportion, 75%, of patients with gonorrheal disease exhibited antibodies against the pilus antigen.
  • The indirect hemagglutination test demonstrated a specificity of 91.7% for detecting gonorrheal disease.
  • The study identified challenges and considerations in interpreting the results of this diagnostic test.

Conclusions:

  • Antibodies against the pilus antigen of Neisseria gonorrhoeae are prevalent in patients with gonorrhea.
  • The indirect hemagglutination assay targeting anti-pilus antibodies shows promise as a diagnostic tool for gonorrhea.
  • Further research is needed to address the complexities in evaluating test results for optimal clinical application.

Related Concept Videos